Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × Estramustine × Clear all

Phase

Status

Sponsor Class

NETWORK 4 OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Carboplatin 265 Paclitaxel 259 Cisplatin 211 Docetaxel 204 pembrolizumab 189 Gemcitabine 180 Pemetrexed 134 Rituximab 125 Capecitabine 124 Bevacizumab 117 Dexamethasone 103 Fluorouracil 97 Cyclophosphamide 91 Doxorubicin 90 Prednisone 84 Trastuzumab 82 Nivolumab 77 Oxaliplatin 74 atezolizumab 64 durvalumab 62 Injections 59 Leucovorin 58 Lenalidomide 56 130-nm albumin-bound paclitaxel 56 Irinotecan 49 Drug Therapy 48 Fulvestrant 46 Bortezomib 46 Letrozole 43 Bendamustine Hydrochloride 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00705822 2010-11-30

PROSTATA

Sanofi

Phase 3 Terminated

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡